The New SNOMED CT International Medicinal Product Model

Olivier Bodenreider, Julie James
2018 International Conference on Biomedical Ontology  
Objectives. To present the new SNOMED CT international medicinal product model. Methods. We present the main elements of the model, with focus on types of entities and their interrelations, definitional attributes for clinical drugs, and categories of groupers. Results. We present the status of implementation as of July 2018 and illustrate differences between the original and new models through an example. Conclusions. Benefits of the new medicinal product model include comprehensive
more » ... ion of clinical drugs, logical definitions with necessary and sufficient conditions for all medicinal product entities, better high-level organization through distinct categories of groupers, and compliance with international standards.
dblp:conf/icbo/BodenreiderJ18 fatcat:humrqtbporaqvaukwpyik7lpn4